04.05.2022 13:40:17
|
Neurocrine Biosciences Inc Q1 Profit Decreases, misses estimates
(RTTNews) - Neurocrine Biosciences Inc (NBIX) announced a profit for first quarter that decreased from last year and missed the Street estimates.
The company's bottom line totaled $13.9 million, or $0.14 per share. This compares with $32.1 million, or $0.33 per share, in last year's first quarter.
Excluding items, Neurocrine Biosciences Inc reported adjusted earnings of $29.7 million or $0.30 per share for the period.
Analysts on average had expected the company to earn $0.35 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 31.3% to $310.6 million from $236.6 million last year.
Neurocrine Biosciences Inc earnings at a glance (GAAP) :
-Earnings (Q1): $13.9 Mln. vs. $32.1 Mln. last year. -EPS (Q1): $0.14 vs. $0.33 last year. -Analyst Estimates: $0.35 -Revenue (Q1): $310.6 Mln vs. $236.6 Mln last year.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Neurocrine Biosciences Inc.mehr Nachrichten
Analysen zu Neurocrine Biosciences Inc.mehr Analysen
Aktien in diesem Artikel
Neurocrine Biosciences Inc. | 111,85 | -0,09% |
|